The Dominantly Inherited Alzheimer Network Expanded Registry (DIAN EXR) is an international research registry for individuals with confirmed or suspected dominantly inherited Alzheimer’s disease (DIAD) in their families and for professionals and researchers involved in clinical care and research on DIAD.
Individuals & Families
Join the DIAN Expanded Registry
Your participation and collaboration help to advance both the understanding and treatment of DIAD. Your enrollment will determine your eligibility for DIAD research studies and clinical trials.
Researchers & Health Professionals
Join the DIAN Expanded Registry
We invite physicians, researchers, genetic counselors and other health professionals so that they can be a part of DIAN-TU and/or DIAN research as a participating research site, as well as refer their patients to DIAN-TU/DIAN research studies.
Who is eligible?
Benefits of joining
Information in the Registry is kept strictly confidential and is securely stored. At any time, you may contact us to remove your information.
The Registry is managed by the DIAN Trials Unit (DIAN-TU) at Washington University School of Medicine in St. Louis. It is funded in part by grants from the Alzheimer’s Association, a consortium of pharmaceutical companies and philanthropic foundations. The Director of the DIAN EXR is Eric McDade, DO.